feed,title,long_url,short_url
Benzinga,"Arvinas, Pfizer's ARV-471 Shows Clinical Benefit Rate Of 40% In Pretreated Breast Cancer Patients",https://benzinga.com/general/biotech/21/12/24546848/arvinas-pfizers-arv-471-shows-clinical-benefit-rate-of-40-in-pretreated-breast-cancer-patients,https://j.mp/3DJrUqP
